User menu

acamprosate supports abstinence, Naltrexone prevents excessive drinking: evidence from a meta-analysis with unreported outcomes,

Bibliographic reference Roesner, S ; Soyka, M ; Leuct, S ; Lehert, Philippe. acamprosate supports abstinence, Naltrexone prevents excessive drinking: evidence from a meta-analysis with unreported outcomes, . In: J Psychopharmacology, Vol. 22 (2007)
Permanent URL http://hdl.handle.net/2078/18765
  1. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders (1987)
  2. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders (1994)
  3. Anton R.F., Am J Psychiatry, 156, 1758 (1999)
  4. Anton Raymond F., O’Malley Stephanie S., Ciraulo Domenic A., Cisler Ron A., Couper David, Donovan Dennis M., Gastfriend David R., Hosking James D., Johnson Bankole A., LoCastro Joseph S., Longabaugh Richard, Mason Barbara J., Mattson Margaret E., Miller William R., Pettinati Helen M., Randall Carrie L., Swift Robert, Weiss Roger D., Williams Lauren D., Zweben Allen, COMBINE Study Research Group for the, Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence : The COMBINE Study: A Randomized Controlled Trial, 10.1001/jama.295.17.2003
  5. Auriacombe M., Abstract CPDD (2000)
  6. Balldin J., Berglund M., Borg S., M??nsson Marianne, Bendtsen P., Franck J., Gustafsson L., Halldin J., Nilsson L.- H., Stolt G., Willander A., A 6-Month Controlled Naltrexone Study: Combined Effect With Cognitive Behavioral Therapy in Outpatient Treatment of Alcohol Dependence : , 10.1097/01.alc.0000075548.83053.a9
  7. Baltieri Danilo Antonio, Andrade Arthur Guerra de, Efficacy of acamprosate in the treatment of alcohol-dependent outpatients, 10.1590/s1516-44462003000300007
  8. Barrias J.A., Psychiatr Clin, 18, 149 (1997)
  9. Begg C.B., J R Soc Aust, 151, 445 (1988)
  10. Berglund M., Treatment of alcohol and drug abuse - an evidence-based review. Swedish Council on Technology Assessment in Health Care (SBU) Volume: Report No. 156 (2003)
  11. Besson Jacques, Aeby Francois, Kasas Antoine, Lehert Philippe, Potgieter Adriaan, Combined Efficacy of Acamprosate and Disulfiram in the Treatment of Alcoholism: A Controlled Study, 10.1111/j.1530-0277.1998.tb04295.x
  12. Borg S., Randomised controlled trial of acamprosate versus placebo in Swedish alcoholics. Unpublished study (2003)
  13. Carmen Bouza, Angeles Magro, Ana Muñoz, María Amate José, Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review, 10.1111/j.1360-0443.2004.00763.x
  14. Chan A.W., Br Med J, 330 (2005)
  15. Chick J., UNITED KINGDOM MULTICENTRE ACAMPROSATE STUDY (UKMAS): A 6-MONTH PROSPECTIVE STUDY OF ACAMPROSATE VERSUS PLACEBO IN PREVENTING RELAPSE AFTER WITHDRAWAL FROM ALCOHOL, 10.1093/alcalc/35.2.176
  16. Chick J., A MULTICENTRE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF NALTREXONE IN THE TREATMENT OF ALCOHOL DEPENDENCE OR ABUSE, 10.1093/alcalc/35.6.587
  17. Chick Jonathan, Lehert Philippe, Landron Frederic, Does Acamprosate Improve Reduction of Drinking As Well As Aiding Abstinence?, 10.1177/0269881103174017
  18. DerSimonian Rebecca, Laird Nan, Meta-analysis in clinical trials, 10.1016/0197-2456(86)90046-2
  19. Gastpar Markus, Bonnet Udo, Böning Jobst, Mann Karl, Schmidt Lutz G., Soyka Michael, Wetterling Tilman, Kielstein Volker, Labriola Dominic, Croop Robert, Lack of Efficacy of Naltrexone in the Prevention of Alcohol Relapse: Results From a German Multicenter Study : , 10.1097/00004714-200212000-00009
  20. Geerlings Peter J., Ansoms Constant, van den Brink Wim, Acamprosate and Prevention of Relapse in Alcoholics, 10.1159/000259166
  21. Gual A., ACAMPROSATE DURING AND AFTER ACUTE ALCOHOL WITHDRAWAL: A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY IN SPAIN, 10.1093/alcalc/36.5.413
  22. Guardia Jose, Caso Carlos, Arias Francisco, Gual Antoni, Sanahuja Jordi, Ramirez Marisa, Mengual Ildefonso, Gonzalvo Begona, Segura Lidia, Trujols Joan, Casas Miguel, A Double-Blind, Placebo-Controlled Study of Naltrexone in the Treatment of Alcohol-Dependence Disorder: Results from a Multicenter Clinical Trial, 10.1111/j.1530-0277.2002.tb02682.x
  23. Hedges L.V., Statistical methods for meta-analysis (1985)
  24. Heinälä Pekka, Alho Hannu, Kiianmaa Kalervo, Lönnqvist Jouko, Kuoppasalmi Kimmo, Sinclair John D., Targeted Use of Naltrexone Without Prior Detoxification in the Treatment of Alcohol Dependence: A Factorial Double-Blind, Placebo-Controlled Trial : , 10.1097/00004714-200106000-00006
  25. Hersh David, Van Kirk Jeffrey R., Kranzler H. R., Naltrexone treatment of comorbid alcohol and cocaine use disorders, 10.1007/s002130050688
  26. Higgins Julian P. T., Thompson Simon G., Quantifying heterogeneity in a meta-analysis, 10.1002/sim.1186
  27. Hopkins J.S., Alcohol Clin Exp Res, 26 (2002)
  28. Kadden R., Cognitive-behavioral coping skills therapy manual: a clinical research guide for therapists treating individuals with alcohol abuse and dependence. NIAAA Project MATCH Monograph Series Vol. 3. NIH Pub. No. 94-3724 (1999)
  29. Keller Mark, On the Loss-of-Control Phenomenon in Alcoholism, 10.1111/j.1360-0443.1972.tb01188.x
  30. Kiefer Falk, Jahn Holger, Tarnaske Timo, Helwig Hauke, Briken Peer, Holzbach Rüdiger, Kämpf Philipp, Stracke Robert, Baehr Michael, Naber Dieter, Wiedemann Klaus, Comparing and Combining Naltrexone and Acamprosate in Relapse Prevention of Alcoholism : A Double-blind, Placebo-Controlled Study, 10.1001/archpsyc.60.1.92
  31. Killeen Therese K., Brady Kathleen T., Gold Paul B., Simpson Kit N., Faldowski Richard A., Tyson Clare, Anton Raymond F., Effectiveness of Naltrexone in a Community Treatment Program : , 10.1097/01.alc.0000145688.30448.2c
  32. Kranzler H, Naltrexone vs. Nefazodone for Treatment of Alcohol Dependence A Placebo-Controlled Trial, 10.1016/s0893-133x(99)00135-9
  33. Kranzler Henry R., Kirk Jeffrey, Efficacy of Naltrexone and Acamprosate for Alcoholism Treatment: A Meta-Analysis, 10.1111/j.1530-0277.2001.tb02356.x
  34. Krystal John H., Cramer Joyce A., Krol William F., Kirk Gail F., Rosenheck Robert A., Naltrexone in the Treatment of Alcohol Dependence, 10.1056/nejmoa011127
  35. Ladewig D., Ther Umsch, 50, 182 (1993)
  36. Latt N.C., Med J Aust, 176, 530 (2002)
  37. Lee Arthur, Tan Shawn, Lim Dominic, Winslow R. M., Wong K. E., Allen John, Hall Wayne, Parker Gordon, Naltrexone in the treatment of male alcoholics - an effectiveness study in Singapore, 10.1080/09595230120058579
  38. Lhuintre Jean-Pierre, Moore NicholasD., Saligaut Christian, Boismare Francis, Daoust Martine, Chretien Pierre, Tran Gilles, Hillemand Bernard, ABILITY OF CALCIUM BIS ACETYL HOMOTAURINE, A GABA AGONIST, TO PREVENT RELAPSE IN WEANED ALCOHOLICS, 10.1016/s0140-6736(85)91615-0
  39. LHUINTRE J. P., MOORE N., TRAN G., STERU L., LANGRENON S., DAOUST S., PAROT Ph., LADURE Ph., LIBERT C., BOISMARE F., HILLEMAND B., ACAMPROSATE APPEARS TO DECREASE ALCOHOL INTAKE IN WEANED ALCOHOLICS, 10.1093/oxfordjournals.alcalc.a045057
  40. Light R.J., Summing up: the science of reviewing research (1984)
  41. Lipha Pharmaceuticals I, Clinical background materials for psychopharmacologic drugs advisory committee meeting. NDA 21-431. Acamprosate for maintenance of abstinence (2002)
  42. Littleton John, Zieglgänsberger Walter, Pharmacological Mechanisms of Naltrexone and Acamprosate in the Prevention of Relapse in Alcohol Dependence, 10.1111/j.1521-0391.2003.tb00492.x
  43. Mann Karl, Pharmacotherapy of Alcohol Dependence : A Review of the Clinical Data, 10.2165/00023210-200418080-00002
  44. Marlatt G.A., Relapse prevention: maintenance strategies in the treatment of addictive behaviours (1985)
  45. Mason B.J., Biol Psychiatry, 48, 77S (2001)
  46. MASON B, GOODMAN A, CHABAC S, LEHERT P, Effect of oral acamprosate on abstinence in patients with alcohol dependence in a double-blind, placebo-controlled trial: The role of patient motivation, 10.1016/j.jpsychires.2006.02.002
  47. Monti Peter M., Rohsenow Damaris J., Swift Robert M., Gulliver Suzy B., Colby Suzanne M., Mueller Timothy I., Brown Richard A., Gordon Alan, Abrams David B., Niaura Raymond S., Asher Marilyn K., Naltrexone and Cue Exposure With Coping and Communication Skills Training for Alcoholics: Treatment Process and 1-Year Outcomes, 10.1111/j.1530-0277.2001.tb02170.x
  48. Morley Kirsten C., Teesson Maree, Reid Sophie C., Sannibale Claudia, Thomson Clare, Phung Nghi, Weltman Martin, Bell James R., Richardson Kylie, Haber Paul S., Naltrexone versus acamprosate in the treatment of alcohol dependence: a multi-centre, randomized, double-blind, placebo-controlled trial, 10.1111/j.1360-0443.2006.01555.x
  49. Morris Philip L. P., Hopwood Malcolm, Whelan Greg, Gardiner John, Drummond Elizabeth, Naltrexone for alcohol dependence: a randomized controlled trial, 10.1046/j.1360-0443.2001.961115654.x
  50. Namkoong K., ACAMPROSATE IN KOREAN ALCOHOL-DEPENDENT PATIENTS: A MULTI-CENTRE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY, 10.1093/alcalc/agg038
  51. Niederhofer Helmut, Staffen Wolfgang, RETRACTED ARTICLE: Acamprosate and its efficacy in treating alcohol dependent adolescents, 10.1007/s00787-003-0327-1
  52. O'Malley Stephanie S., Naltrexone and Coping Skills Therapy for Alcohol Dependence : A Controlled Study, 10.1001/archpsyc.1992.01820110045007
  53. O'Malley S.S., Recent Dev Alcohol, 16, 217 (2003)
  54. O'Malley Stephanie S., Rounsaville Bruce J., Farren Conor, Namkoong Kee, Wu Ran, Robinson Jane, O'Connor Patrick G., Initial and Maintenance Naltrexone Treatment for Alcohol Dependence Using Primary Care vs Specialty Care : A Nested Sequence of 3 Randomized Trials, 10.1001/archinte.163.14.1695
  55. Oslin David, Liberto Joseph G., O'Brien John, Krois Stacy, Norbeck Jennifer, Naltrexone as an Adjunctive Treatment for Older Patients With Alcohol Dependence, 10.1097/00019442-199700540-00007
  56. Paille F.M., Alcohol Alcohol, 30, 239 (1995)
  57. Pelc I., Acamprosate in the treatment of alcohol dependence: a six month postdetoxification study (1992)
  58. Pelc I., Verbanck P., Le Bon O., Gavrilovic M., Lion K., Lehert P., Efficacy and safety of acamprosate in the treatment of detoxified alcohol-dependent patients. A 90-day placebo-controlled dose-finding study, 10.1192/bjp.171.1.73
  59. POLDRUGO F., Acamprosate treatment in a long-term community-based alcohol rehabilitation programme, 10.1111/j.1360-0443.1997.tb02873.x
  60. Rousseaux J.P., J Pharm Belg, 51, 65 (1996)
  61. Rybakowski J.K., Abstract ESBRA (1997)
  62. Sass Henning, Relapse Prevention by Acamprosate : Results From a Placebo-Controlled Study on Alcohol Dependence, 10.1001/archpsyc.1996.01830080023006
  63. Schoechlin Claudia, Engel Rolf, Meta-Analysis of Pharmacotherapeutic Trials, Handbook of Alcoholism (2000) ISBN:9780849378010 p.339-351, 10.1201/9781420036961.ch31
  64. Sinclair J. D., Evidence about the use of naltrexone and for different ways of using it in the treatment of alcoholism, 10.1093/alcalc/36.1.2
  65. Slattery J., Prevention of relapse in alcohol dependence. Health Technology Assesment Report 3 (2003)
  66. Yuferov Vadim, Bart Gavin, Kreek Mary Jeanne, Clock reset for alcoholism, 10.1038/nm0105-23
  67. Srisurapanont M., Cochrane Database Syst Rev, 2, CD001867 (2001)
  68. Srisurapanont M., J Psychopharmacol, 8, 267 (2005)
  69. Streeton C., NALTREXONE, A RELAPSE PREVENTION MAINTENANCE TREATMENT OF ALCOHOL DEPENDENCE: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS, 10.1093/alcalc/36.6.544
  70. Supnick Jay A., Colletti Gep, Relapse coping and problem solving training following treatment for smoking, 10.1016/0306-4603(84)90041-8
  71. Tempesta E., ACAMPROSATE AND RELAPSE PREVENTION IN THE TREATMENT OF ALCOHOL DEPENDENCE: A PLACEBO-CONTROLLED STUDY, 10.1093/alcalc/35.2.202
  72. Volpicelli Joseph R., Naltrexone in the Treatment of Alcohol Dependence, 10.1001/archpsyc.1992.01820110040006
  73. Effect of naltrexone on alcohol "high" in alcoholics, 10.1176/ajp.152.4.613
  74. Volpicelli Joseph R., Naltrexone and Alcohol Dependence : Role of Subject Compliance, 10.1001/archpsyc.1997.01830200071010
  75. Wasserman David A, Weinstein Meryle G, Havassy Barbara E, Hall Sharon M, Factors associated with lapses to heroin use during methadone maintenance, 10.1016/s0376-8716(98)00092-1
  76. Whitworth A.B, Oberbauer H, Fleischhacker W.W, Lesch O.M, Walter H, Nimmerrichter A, Platz T, Fischer F, Potgieter A, Comparison of acamprosate and placebo in long-term treatment of alcohol dependence, 10.1016/s0140-6736(96)91682-7
  77. Williamson P. R., Gamble C., Identification and impact of outcome selection bias in meta-analysis, 10.1002/sim.2025